In an animal model, FXR-null mice have been shown to develop dyslipidemia and hepatic steatosis, and they exhibit a proatherogenic lipoprotein profile with markedly elevated serum and hepatic cholesterol and triglycerides [79]. Here, NR1H4 is linked to fatty liver disease.